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SHORT TITLE:  Post-Discharge Mortality Prediction 
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Low-income countries (LIC) 
Manhiça Health Research Center (CISM) 
Manhiça District Hospital (MDH)  
Demographic surveillance system (DSS)  
Morbidity surveillance system (MSS)  
Human immunodeficiency virus (HIV) 
International Statistical Classification of Diseases (ICD) 
Kaplan-Meier (KM) 
Severe acute malnutrition (SAM) 
HR: hazard ratio 
Weight-for-age Z-score (WAZ) 
Weight-for-height Z-score (WHZ) 
Low birth weight (LBW) 
Management of Childhood Illness algorithm (IMCI) 
Mass drug administration (MDA) 
 
TABLE OF CONTENTS SUMMARY:  This study shows the burden of post-
discharge mortality in Southern Mozambique, identifying predictors which could 
efficiently stratify children with higher risk of dying following a hospital discharge.  
 
WHAT’S KNOWN ON THIS SUBJECT: Post-discharge mortality is an important 
contributor to child mortality, ranging between 3.3% and 13%, although it is poorly 
recognized. No predictive models of post-discharge mortality among all cause-
admissions in resource-constrained hospitals or among infants have been developed to 
date.  
 
WHAT THIS STUDY ADDS: Predictive models presented in this study could be 
applied at hospital discharge and children at risk of dying could be identified through 
their use. This could allow designing a better post-discharge planning, health education 
to the families and follow-up care.  
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ABSTRACT 
Background: Although the burden of post-discharge mortality (PDM) in low-income 
settings appears significant, no clear recommendations have been proposed in relation to 
follow-up care after hospitalization. We aimed to determine the burden of paediatric 
PDM and develop predictive models to identify children at risk of dying following 
discharge. 
Methods: Deaths after hospital discharge among children aged <15 years in the last 17 
years were reviewed in an area under demographic and morbidity surveillance in 
Southern Mozambique. We determined PDM over time (up to 90 days) and derived 
predictive models of PDM using easily collected variables upon admission.  
Results: Overall PDM was high (3.6%), with half of deaths occurring in the first 30 
days. One primary predictive model for all ages included young age, moderate/severe 
malnutrition, history of diarrhoea, clinical pneumonia symptoms, prostration, 
bacteraemia, positive HIV status, rainy season and transfer or absconding, with an area 
under the curve (AUC)  of 0.79 (0.75-0.82) at day 90 after discharge. Alternative 
models for all ages including simplified clinical predictors had a similar performance. A 
model specific to infants <3 months identified as predictors: being a neonate, low WAZ 
score, breathing difficulties, hypothermia or fever, oral candidiasis and history of 
absconding or transfer to another hospital, with an AUC of 0.76 (0.72-0.91) at day 90 of 
follow-up. 
Conclusions: Death following discharge is an important although poorly recognized 
contributor to child mortality. A simple predictive algorithm based on easily 
recognizable variables could readily identify most infants and children at high risk of 
dying after discharge. 
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BACKGROUND 
The last 25 years have witnessed a significant (49%) reduction in under-5  child 
mortality globally
1
, but an insufficient one to meet the two thirds reduction objective set 
by the fourth millennium development goal, particularly among many low-income 
countries (LIC)
2
.  
In the last decades, algorithms for diagnosis and treatment of sick children have been 
implemented in order to address the management of disease during the acute phase and 
have contributed to improve child survival
3
. Such guidelines and recommendations, 
however, have historically failed to address the days immediately following 
hospitalization, a critical period for child survival
4
.  
Contrary to what occurs in industrialized countries, where post-discharge mortality 
(PDM) is limited to certain small, high-risk groups
5, 6
, children in LIC appear to be at 
increased risk of mortality following hospitalisation for any illness
4, 7-13
. Previous 
studies among admitted children, albeit scarce, have estimated risk of PDM to range 
between 3.3% and 13%
9, 14, 15
. For specific diseases, PDM risks have ranged between 
2.0-2.6% for malaria
16, 17
, 2.9 to 7% for diarrhoea
18, 19
, 2.7-11.6% for anaemia
20
,  1-15% 
for pneumonia
15, 21
 , and 2.8% for invasive bacterial infections
7
. Most of these deaths 
have been described to cluster in the first 30 days
13
 and main predictors of PDM include 
a history of previous hospitalizations, young age, HIV infection and hospitalizations 
related to malnutrition or pneumonia
4
.  
A rigorous follow-up of all hospital discharged children would be unfeasible and 
unaffordable for resource-constrained settings
13
. Thus, early identification of vulnerable 
children appears essential to design more targeted interventions to prevent PDM
13
. 
Improving the discharge process and post-discharge care will be a critical step to further 
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continue reducing child mortality
4
. We therefore aimed to determine the burden of 
paediatric PDM in a semi-rural area from southern Mozambique, to identify predictors 
of mortality following discharge and to derive models that could efficiently stratify 
children according to PDM risk. 
 
METHODS 
Study site and population 
This study was conducted in Manhiça, southern Mozambique, a semi-rural setting with 
a predominantly young population (45% <15 years of age). In 2015, the national under-
5 mortality rate was 78·5/1000 live births
22
. Manhiça Health Research Centre (CISM), 
runs a demographic surveillance system (DSS) in the area, and a paediatric morbidity 
surveillance system (MSS) has been implemented for nearly two decades at the 
neighbouring Manhiça District Hospital (MDH) and five additional peripheral health 
posts, accurately capturing standardized morbidity data for ~3000 admissions and 
>75,000 annual outpatient visits, annually. Human immunodeficiency virus (HIV) 
prevalence in the area is among the highest in the world
23
, with adult community 
prevalence peaking at 40%
24
. Vertical transmission of HIV has been estimated at around 
9%
25
 and contributing 10% to the under-5 mortality nationally
26
.  A detailed description 
of CISM and study area can be found elsewhere
27, 28
.  
 
Study design and definitions 
A retrospective cohort study of children <15 years discharged from MDH for a 17 year-
long period was conducted, using the DSS and MSS databases. We analysed burden of 
PDM over three different time-periods: First (1-30 days), second (31-60 days) and third 
month (61-90 days) post-discharge. PDM among infants <3 months old was analysed 
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separately to check whether identified predictors differed from those of the older cohort. 
Only children living in the study area were included. We used a single-discharge 
approach, considering the first admission as reference admission, and not considering 
ulterior re-admissions within the following 90 days to avoid re-starting the period at risk 
every time. Post-discharge death was defined as a death occurring >24 hours after and 
within 90 days of discharge from MDH;  community death as a death ocurring outside a 
health facility within 90 days after discharge; and facility death as a death ocurring at 
any health facility within 90 days following discharge from MDH. Chidren dying 
during a readmission within the follow-up period were considered as a hospital death 
within follow-up (supplementary figure S1). Supplementary table S1 summarizes other 
relevant definitions.  
 
Morbidity surveillance system. 
Morbidity surveillance data routinely collected for all children <15 years during the 
study period were analysed, including clinical data, basic laboratory investigations 
(malaria microscopy, haematocrit and glycaemia) and International Statistical 
Classification of Diseases-based diagnoses (ICD-10) since 2003. All diagnoses prior to 
July 2003 were coded according to a list of codes created by the CISM since 1996. 
Outcome and medications prescribed were also analysed. For admitted children, blood 
culture results, systematically performed for all children <2 years and, in older children, 
in those with severe disease, were available. HIV status information, although not 
routinely collected, was available for those patients with suspected immunosuppression.  
 
Demographic Surveillance System  
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CISM’s DSS, which started in 1996, now covers the entire Manhiça District (2380 km
2
;  
total population of ~183000 inhabitants). DSS captures socio-demographic data and 
other major events like migration, marital status, pregnancy and outcome results, births 
and deaths and is updated twice annually. During periods in which the entire district 
was not covered, analysis only included inpatients being part of the DSS. Through a 
unique identifier number, DSS and MSS databases can be linked.  
 
Data management and data analysis 
A survival analysis was performed to model events within 90 days of discharge. The 
discharge date+1 day was used as date of entry to the study whilst post-discharge death, 
loss to follow-up or end of follow-up period (90 days after discharge), considered the 
exit time. For each variable with a high proportion of missing values (<15%) but 
suspected to be a strong confounder, a “missing or unknown” category was created. In 
order to achieve the study objectives, data analysis was split in two parts: a) 
Determining burden and identifying associations: Descriptive statistics were calculated 
for all explanatory variables. Kaplan-Meier (KM) curves were produced for all 
categorical predictors to look for differences in survival with different values of the 
predictor. Associations between potential predictors and risk of death after discharge 
were explored in univariable Cox regression models. b) Selecting and validating 
predictive models: The dataset was randomly split into two subsets (training set 
containing 80% of data and the validation set with the remaining 20%) which were then 
compared to confirm that there were no important differences between the two subsets. 
Those predictors showing evidence of an association (p-value ≤0.05) with the outcome 
in a univariable analysis were selected for potential inclusion in a multivariable Cox 
regression model (primary model). Three additional models were also examined based 
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on their suitability for different contexts: Model 2), which uses the primary model as 
reference, but includes only variables with minimal costs; Model 3) based exclusively 
on clinical variables collected on admission; and Model 4) predictors of PDM restricted 
to infants <3months. The area under the curve (AUC) was plotted for each model over 
time using the training set (formula: H(t) = H0(t) x exp(b1X1 + b2X2 + b3X3 + ... + 
bkXk) ). Confidence intervals of AUC were estimated by 1000 bootstrap replicates using 
the bias-corrected percentile method
29
. As there could be more than one admission for 
some children, the models described above were estimated taking into account within-
child clustering. Analyses used Stata Statistical software (Release 15). Graphical 
representation of AUC curves was done in R (R Core Team; 2017) using 
the survivalROC package. 
 
Ethical considerations 
This study examined data collected in the context of routine clinical practice. DSS and 
MSS ongoing in the study area have been approved by the National Ethics Committee 
of Mozambique.  
 
RESULTS  
Overall characteristics of study population 
From 1
st
 January 2000 to 31
st
 December 2016, 58990 inpatient records were checked of 
which 29574 (50%) were initially excluded (figure 1). 3097 observations of children 
living in study area readmitted within follow-up (supplementary figure S1), hospital 
deaths (2.5%, 662/26319 of remaining children) and 25 deaths in the first 24 hours 
(<0.1%) were also excluded (figure 1). Thus, 25632 inpatient records of 18023 children 
<15 years old admitted to MDH were included in the analysis (Table 1). 2055 
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observations of 2049 infants <3months were also analysed separately (supplementary 
table S2).  
  
Incidence of post-discharge deaths and potential predictors of PDM 
During the 90-day follow-up period, 935 (3.6%) deaths after discharge occurred among 
the 25632 admissions, with 783/935 (83.7%) occurring at the community level and 
488/935 (52.2%) within the first 30 days of discharge. Median time to death was 28 
days (IQR 11-53). The risk of post-discharge deaths varied over time (figure 2A and 
supplementary figure S2) and by age (figure 2B) similarly to the risk of inpatient 
mortality (figure 2C).   
Forty-five variables were tested for their univariable association with PDM (table 1). 
Infants <3months were more likely to die than older children (figure 3A; supplementary 
table S2). Similarly, poorer nutritional levels were clearly linked to PDM (figure 3B).  
 
Predictive models and validation 
Supplementary table S3 presents the comparison of the training and validation sets. 
Nineteen variables were associated with higher risk of PDM in the multivariate analysis 
(primary model, table 2). Infants less than 3 months had the highest rate of PDM and 
this decreased with increasing age (p<0.001) (supplementary table S4). The rate of 
PDM varied between rainy and dry seasons (HR 1.22, 95% CI 1.03-1.43). Severe acute 
malnutrition (SAM) (HR 3.26, 95% CI (2.08-5.12) as well as other 13 clinical variables 
were associated with PDM. Children with a positive blood culture (HR 1.68, 95% CI 
1.33-2.12) and a positive HIV test (HR 1.77, 95% CI 1.07-2.91) also had a higher rate 
of death during the follow-up period. Absconding (HR 5.23, 95% CI 4.22-6.50) or 
referral to a higher level of health care (HR 4.48, 95% CI 3.31-6.05) were clearly 
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associated with death. Children with a malaria diagnosis had a lower risk of PDM (HR 
0.44, 95% CI 0.36-0.54). The AUC for this model was around 0.80 during the 90 days 
follow-up period, being, at day 90, 0.79 (95% CI 0.75 - 0.82). At a HR cut-off point of 
1.08, it had a sensitivity of 80%, specificity of 60% and a positive predictive value 
(PPV) of 6.9% (figure 4 and table 3).  According to this model, 1.9% of all discharges 
will die in the first 90 days after discharge.  
 
Time-varying AUC of the two additional simplified models (table 2), is compared in 
supplementary figure S3A. Model 2, which excluded blood culture but maintained 
minimal cost tests, performed similarly to the primary model, with an AUC around 
0.80% until 60 days after discharge. Model 3, which included only clinical variables, 
performed slightly worse, with an AUC ~0.75 during the whole period. Model 4, limited 
to infants <3months, included variables such as breastfeeding and weight-for-age 
(WAZ) to assess nutritional status, on account of the excess of missing height data. 
Neonates appeared to have the highest risk of PDM among this age group 
(supplementary table S4). This model had an AUC at day 30 of 0.84 (95% CI 0.72 - 
0.91) and at day 90 of 0.76 (95% CI 0.72 - 0.91). At a HR cut-off point of 0.5, it had a 
sensitivity of 79%, specificity of 53% and a PPV of 12.8% (table 3 and supplementary 
figure S3B). AUC and model’s characteristics at probability cut-offs ensuring 
sensitivity of >80% are shown in table 5. CI of AUC between training and validation set 
and between primary model and the other models overlapped, meaning no significant 
differences between them were found.  
 
DISCUSSION 
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This analysis, based on more than 20000 hospital discharges and 935 post-discharge 
deaths, is the largest study to date evaluating PDM in the first three months following 
hospital discharge from a rural district hospital in a LIC, and represents a systematic 
approach to ascertain predictors of PDM in a resource-constrained environment.  
The cumulative three-month post discharge mortality found in this study (3.6%) is 
lower than that reported in the 1990s from other African settings, where incidence risk 
was estimated between 6.1% and 13%
14, 15
, but similar to other more recent PDM 
studies
7, 9, 10, 18
. Importantly, inpatient mortality found in our cohort (2.5%) aligned 
closely with that reported in other settings
13, 14
.  
 
These findings highlight that risk of dying is greatest in the first 30 days immediately 
following discharge
7, 10
, the most critical period for survival
10, 15, 18
. Overall, trends of 
post-discharge mortality for all ages changed over time. PDM rates increased over the 
period from 2000-2010, subsequently declining. This trend cannot be explained by an 
increase in inpatient mortality, as this was progressively decreasing since 2001 (figure 
2C). One could speculate that variations in the epidemiology of a single disease may 
have played a significant role in PDM variations (Supplementary figure S4). For 
instance, malaria used to be highly endemic in the area at the beginning of the study 
period, with a subsequent declining trend observed from the year 2005 onwards, trends 
inversely proportional to those of the PDM curve. Children admitted with malaria, 
readily treatable and with a rapid recovery, are probably less likely to be associated with 
post-discharge complications. This could partly explain why a diagnosis of clinical 
malaria has been shown to be an overall protective factor against PDM (HR 0.44, 95% 
CI 0.36-0.54) a finding also reported in Kenya
9
. Similarly, although HIV incidence is 
now much higher in the area than it was a decade ago, the increasing uptake of 
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antiretroviral drugs probably implies a better control of this infection on PDM in recent 
years when more admissions due to HIV have been registered. Trends in the proportion 
of children admitted with other diseases with greater incidence of post-discharge deaths, 
such as SAM, showed an overall tendency parallel to the PDM curve over time. 
However, the declining trend of PDM seen at the end of the study period cannot be 
exclusively explained by malaria, HIV or SAM trends. The progressive introduction of 
other life-saving interventions, such as vaccination against Hib (2009), pneumococcus 
(2013), and rotavirus (2015) have reduced hospital admissions and, may also have 
contributed to these decreasing trends. PDM trends over time among infants <3 months 
differed slightly from other age groups, with a peak in 2003, and stable rates thereafter. 
In this highly vulnerable age group, effective interventions specifically designed to 
reduce mortality, have not been fully implemented in the study area.  
 
The primary model, including all available useful variables performed remarkably well, 
particularly to predict risk of dying in the first month following discharge. This model 
predicts that 1.9% of children discharging from the hospital will die in the first 90 days 
following discharge. Applying a score based on this model to a population similar to 
ours and using a HR cut-off of 1.08, roughly 80% of children likely to die following 
discharge would be identified and the referral population would have a mortality risk of 
approximately 7%. This model however includes blood culture results, an expensive 
determination that requires laboratory infrastructures seldom available in poor settings. 
The two alternative simplified models, including more easy-to-collect lab results 
(Model 2) or only clinical variables (Model 3) seem more applicable, and still showed a 
good predictive capacity for PDM. Importantly, model 4, developed for infants <3 
months old, uses only few variables, all of them easily and readily obtainable in most 
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resource constrained contexts and could identify 0.85 of infants <3months at risk of 
dying in the first days after discharge and nearly 0.80 during the remaining follow-up 
period. 
Severe acute malnutrition is a recognized predictor of PDM
8-10, 13, 18
 as our models 
confirm. The chronicity of malnutrition, the fact that it can predispose to an array of co-
infections and complications, and its association with HIV infection in Manhiça
30
, may 
all contribute to explain its associated prolonged mortality risk. On the other hand, 
children with unknown nutritional status had higher risk of dying compared to well-
nourished children. This may be partly explained in cases of severe disease, where the 
severity of the child upon admission did not allow collecting anthropometric 
measurements. HIV positivity, a clear predictor of PDM
13, 20
, remained in our model a 
strong independent predictor, even after adjusting for malnutrition. Rainy season was 
also associated to higher risk of PDM as more children are admitted during this season, 
likely due to the greater number of admissions and severe disease occurring in this 
season. 
In this series, type of outcome at discharge, and particularly being transferred or 
absconding from hospital, were the greatest predictors of PDM. In this setting, children 
are usually transferred to a higher-level health facility whenever they are very sick or 
when they require a more specialized evaluation or supportive care, justifying their 
greatest PDM risk. Children absconding against medical recommendations (3.1% of the 
study sample) had an extremely high risk of post-discharge mortality, and represent one 
out of every five deaths in our series. In Manhiça, absconding is a cultural and financial 
phenomenon, typically occurring when families anticipate a bad outcome and prefer 
their children to die at home, additionally sparing costs associated with the transport of 
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a corpse. Socio-behavioural studies addressing this phenomenon and the perceptions of 
health professionals of its serious consequences are needed.  
 
The majority (83.7%) of deaths following hospital discharge occurred at the 
community, in the absence of any further contact with the health system. A study 
investigating cause of death in Manhiça using verbal autopsies documented that 53% of 
all paediatric deaths occurred at home
28
. These alarming figures reflect the generalized 
challenges in access to care, which become even more blatant following hospital 
discharge.  
Effective models for identifying children at risk of PDM should take into consideration 
the existing resources but consider illness as a continuum transcending the information 
that the admission snapshot can provide. A score or similar algorithm to that proposed 
by IMCI, based in predictive models and applied at discharge, could pinpoint children 
requiring a more rigorous follow-up after hospitalization. However, the identification of 
high risk does not imply that risk can be reduced. Future research should consider 
validation of these models in different contexts and prospectively assessing their 
accuracy to identify children at risk of dying after discharge in resource-constrained 
settings. Once identified, these children at higher risk of PDM could benefit from 
strategies to prevent post-discharge death and these strategies should especially focus in 
the first 30 days after discharge as it is the period with the highest risk of PDM. 
Community-based interventions driven by community-health workers consisting in pre 
and post-natal home visits, supporting low birth-weight (LBW) infants and sepsis case 
management, facilitating referral in case of need have reduced neonatal and infant 
mortality in several countries
31
. Although these interventions have not been explored in 
children after a hospital admission, their impact reducing PDM could be similar. 
Page 16 of 46
https://mc.manuscriptcentral.com/pediatrics
Confidential - Not for Circulation
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
Review Copy
Alternative strategies, utilizing the prophylactic use of antimicrobials in those children 
at high risk should also be explored. A recent clinical trial conducted in Kenya 
exploring the efficacy of daily post-discharge co-trimoxazole prophylaxis in children 
admitted with complicated SAM without HIV found however no reduction in mortality 
during the first year after admission
32
. 
 Continued investment in child mortality data collection and understanding 
circumstances of paediatric death following a hospital discharge is needed in order to 
design innovative, effective and feasible strategies to reduce the risk of childhood 
preventable deaths after hospitalization. 
 
This study has several limitations, including its retrospective nature. Selection bias may 
arise due to the fact that almost half of children admitted to MDH between 2000 and 
2016 were excluded and this might affect the representativeness of the study sample. 
Another limitation includes the fact that all clinical predictors were collected at the time 
of admission, and some these clinical variables may have changed throughout the 
hospitalization. We decided to use a single-discharge approach within 90 days of 
follow-up to avoid double counting time at risk, excluding observations of children re-
admitted during the follow-up period. This strategy may have resulted in a clearer 
picture of the true community PDM but also in an underestimation of the likely higher 
real-life true incidence. Another factor potentially underestimating PDM is the 
exclusion of deaths occurring in the first 24 hours after discharge, as they were 
considered as hospital deaths. However, they merely represented <0.1%. The inclusion 
of children who were transferred or absconded from the hospital may be overestimating 
the incidence of PDM since they were not officially discharged, but this is an extremely 
frequent occurrence in African settings, and needs to be taken into consideration, 
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particularly in the light of the strength and magnitude of the statistical associations 
found. Importantly, we could not assess the role of LBW in infants as a likely risk factor 
for PDM, since this information was not available. On the other hand, the low 
specificity and positive predictive value found could compromise feasibility of 
interventions to prevent PDM, as a high number of children would be classed as high 
risk of dying after discharge. However, these models would allow the identification of 
the majority of children with risk of PDM. Finally, our predictive models lack an 
external validation.  
 
Conclusion 
This study highlights the importance and oversight of post discharge mortality as a 
significant portion of the childhood mortality pie. Simple models including predictors 
easily collected with minimal cost, such as those presented in this article, need to be 
prospectively validated in different circumstances and settings. Specific interventions 
targeting children identified to be at higher risk and guaranteeing their adequate follow-
up at the hospital or even at the household level could possibly increase their survival 
possibilities. Implementation of such strategies could prevent avoidable deaths, 
especially among neonates and infants who suffer the highest burden of PDM. 
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Exclusions
935 (3.6) children who died during the 90 day period after discharge
* 783 non-hospital deaths within follow-up
* 152 facility deaths within follow-up (during readmission)
58990 inpatient records of children <15 years of age admitted to 
Manhiça's District hospital during study period                                   (1st 
Jan. 2000- 31st Dec. 2016)
25632 observations of 18023 children included in the analysis
HOSPITAL 
TIMING OF DEATH: 
1 to 30 days post discharge
488 (52.2%) deaths
(1.90% of all children included in 
analysis) 
TIMING OF DEATH: 
31 to 60 days post discharge
265 (28.3%) deaths
(1.03% of all children included in 
analysis) 
TIMING OF DEATH: 
61 to 90 days post discharge
182 (19.5%) deaths
(0.71% of all children included in 
analysis) 
28700 observations of children non-resident in study area
94 observations of children with missing admission or discharge date
171 observations of children with missing outcome
233 observations of children with discharge date before admission date
21 observations of children with admission date before discharge from a previous admission 
309 observations with error in admission date
7 observations of children with admission date before birth date
39 observations of children with admission date after death
3097 observations of children living in study area readmitted within follow-up
662 Hospital deaths of children living in study area 
25 Deaths in the first 24 hours after discharge
Figure 1. Study profile 
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Figure 2: Mortality trends over time during the 17 year-long study period 
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1 
 
Figure 3: Kaplan-Meier failure estimates for 935 deaths during 90 days follow-up after discharge from Manhiça District Hospital. 
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Table 1. Socio-demographic, clinical characteristics and univariate analysis of  
predictors on admission associated to post-discharge mortality in southern 
Mozambique, based on 25632 observations and 935 post-discharge deaths. 
Characteristics on 
admission 
Total 
observations 
included,    
N= 25632,          
n (%)       
Children dying 
within 90 day 
after dischargeᵝ 
N= 935,  n (%ʱ) 
Univariate 
HRᵠ 
95 % CI* p valueᶿ 
Demographic 
characteristics 
          
Age             <0·001 
< 3 months  2055 (8·0) 126 (6·1) 1·00     
4 to < 1year 5203 (20·3) 276 (5·3) 0·86 0·70  to  1·06 0·164 
1 to 5 years 14558 (56·8) 450 (3·1) 0·50 0·41  to  0·60 <0·001 
> 5 years 3816 (14·9) 83 (2·2) 0·35 0·26  to  0·46 <0·001 
Female sex  11571 (45·3) 425 (3·7) 1·01 0·89 to 1·15 0·838 
Rainy season 15624 (61·0) 602 (3·9) 1·16  1·02 to 1·33 0·029 
Anthropometric  
characteristics  
          
Weight for height-z 
score (mean ±SDᶧ) 
-0·93 (0·01) -1·99 (0·13) 0·63 0·57 to 0·69 <0·001 
Nutritional status by 
WHZᶤ z-score 
        <0·001 
>-1 SDᶧ 5994 (23·4) 57 (0·9) 1·00     
>-2 to <-1 SDᶧ 2749 (10·7) 35 (1·3) 1·34 0·88 to 2·04 0·172 
>-3 to <-2 SDᶧ 1486 (5·8) 34 (2·3) 2·42 1·58 to 3·71 <0·001 
< -3 SDᶧ 1030 (4·0) 57 (5·5) 5·94 4·12 to 8·57 <0·001 
Unknown 14373 (56·1) 752 (5·2) 5·62 4·30 to 7·36 <0·001 
History of current 
diseaseᵜ 
          
History of fever 23424 (91·4) 797 (3·4) 0·54 0·45 to 0·64 <0·001 
History of cough 16324 (63·7) 705 (4·3) 1·78 1·53 to 2·06 <0·001 
History of diarrhoea 5015 (19·6) 336 (6·7) 2·36 2·06 to 2·69 <0·001 
History of vomiting 6004 (23·4) 268 (4·5) 1·32 1·15  to 1·52 <0·001 
History of breathing 
difficulties 
5303 (20·8) 298 (5·6) 
1·81 
1·58 to 2·08 <0·001 
Anorexia 1648 (6·5) 101 (6·1) 1·79 1·46 to 2·20 <0·001 
Blood in urine 97 (0·4) 5(5·2) 1·43 0·59 to 3·44 0·429 
History of seizures  2658 (10·4) 39 (1·5) 0·37 0·27 to 0·51 <0·001 
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Symptoms and signs on 
admission 
          
Axillary temperature  (ºC)          <0·001 
Normothermia (35.5-
37.4ºC) 
9840 (37·0) 427 (4·3) 1·00     
Hypothermia (<35.5ºC) 513 (2·0) 30 (5·8) 1·31 0·90 to 1·89 0·158 
Fever (≥37.5ºC) 15598 (61·0) 476 (3·1) 0·67 0·59 to 0·77 <0·001 
Heart rate          0·647 
Normal 16697 (65·5) 600 (3·6) 1·00     
Bradycardia 1902 (7·5) 75 (3·9) 1·10 0·87 to 1·40 0·436 
Tachycardia 6876 (27·0) 259 (3·8) 1·05 0·90 to 1·21 0·518 
Increased respiratory 
rate 
11560 (45·3) 351 (3·0) 1·37 1·20 to 1·57 <0·001 
Skin pinch goes back 
slowly  
2007 (8·1) 186 (9·3) 3·03 2·58 to 3·56 <0·001 
Dehydration 3907 (15·3) 248 (6·3) 2·04 1·77 to 2·37 <0·001 
Pallor 4228 (16·5) 141 (3·3) 0·90 0·75 to 1·07 0·227 
Jaundice 328 (1·1) 8 (2·4) 0·66 0·33 to 1·32 0·243 
Oedema (any location) 1371 (5·4) 130 (9·5) 2·96 2·46 to 3·57 <0·001 
Skin flaking off 464 (1·8) 46 (9·9) 2·90 2·15 to 3·90 <0·001 
Depigmented or redish 
hair 
1460(5·7) 216 (14·8) 5·30 4·55 to 6·18 <0·001 
Oral candidiasis 493 (1·9) 108 (21·9) 7·44 6·08 to 9·09 <0·001 
Swollen lymph nodes 827 (3·2) 113 (13·7) 4·33 3·56 to 5·25 <0·001 
Conjunctivitis 416 (1·6) 24 (5·8) 1·62 1·08 to  2·43 0·020 
Ear discharge 641 (2·5) 57 (8·9) 2·59 1·98 to 3·38 <0·001 
Lower chest wall 
indrawing 
5488 (21·4) 298 (5·4) 1·73 1·51  to 1·99 <0·001 
Nasal flaring 4123 (16·1) 206 (5·0) 1·48 1·27  to 1·73 <0·001 
Pathological breathing 
pattern 
1018 (3·7) 54 (5·3) 1·50 1·14 to 1·97 0·004 
Auscultatory crackles 5314 (20·8) 320 (6·0) 2·02 1·77 to 2·31 <0·001 
Wheeze/roncus 3090 (12·1) 127 (4·1) 1·15 0·96 to 1·39 0·138 
Heart gallop 882 (3·4) 32 (3·6) 0·99 0·70 to 1·41 0·972 
Palpable liver 677 (2·6) 38 (5·6) 1·57 1·14 to 2·18 0·006 
Palpable spleen 5378 (21·0) 145 (2·7) 0·69 0·58 to 0·82 <0·001 
Neck stiffness 203 (0·8) 11 (5·4) 1·51 0·83 to 2·74 0·175 
Abnormal fontanel 
(among applicable) 
922 (8·7) 70 (7·6) 1·55 1·21 to 1·99 <0·001 
Prostration 3261 (13·0) 146 (4·5) 1·29 1·08 to 1·54 0·005 
BCS on admission          0.047 
Normal (BCS=5) 24320 (95·0) 870 (3·6) 1·00     
Abnormal BSC (BCS=3-4) 873 (3·4) 39 (4·5) 1·26 0·91 to 1·73 0·164 
Deep coma (BCS≤2) 396 (1·6) 22 (5·6) 1·57 1·03 to 2·41 0·037 
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Investigations           
Malaria diagnosis         <0·001 
Negative 9431 (36·8) 581 (6·2) 1·00     
Positive 12232 (47·7) 202 (1·7) 0·26 0·22 to 0·31 <0.001 
Test not done 3969 (15·5) 152 (3·8) 0·61 0·51 to 0·74 <0·001 
Glycaemia         0.189 
Normoglycaemia (2.5-
11.0 mmol/l) 
21384 (83·4) 798 (3·7) 1·00     
Hypoglycaemia (<2.5 
mmol/l) 2413 (9·4) 83 (3·4) 0·92 0·73 to 1·15 0·471 
Hyperglycaemia (>11.0 
mmol/l) 1835 (7·2) 54 (2·9) 0·78 0·60 to 1·03 0·084 
Blood culture           
Negative 24316 (94·9) 798 (3·3) 1·00     
Positive 1296 (5·1) 136 (10·5) 3·32 2·77 to 3·98 <0·001 
Anaemia         0·902 
No anaemia 8806 (34·4) 319 (3·6) 1·00     
Mild to moderate 
anaemia 13624 (53·1) 495 (3·6) 1·00 0·87 to 1·15 0·997 
Severe anaemia 3202 (12·5) 121 (3·8) 1·04 0·84 to 1·28 0·709 
HIV status         <0·001 
Test not done 24128 (94·1) 867 (3·6) 1·00     
Negative 1246 (4·9) 25 (2·0) 0·55 0·37 to 0·82 0·004 
Positive 258 (1·0) 43 (16·7) 4·97 3·59 to 6·88 <0·001 
Outcome of the 
admissionᵑ 
          
          <0·001 
Discharged alive 24145 (94·2) 666 (2·8) 1·00     
Absconded 805 (3·1) 161 (20·0) 8·18 6·87 to 9·74 <0·001 
Transferred 682 (2·7) 108 (15·8) 6·30 5·12 to 7·75 <0·001 
ᶧSD: standard deviation. ᶤWHZ: Weigh-for-height. See definitions in Table S1. ᵝIt refers both to 
community deaths and deaths in a readmission during follow-up period. ʱPercentage represents risk 
among children with same characteristics. ᵠ HR: Hazard ratios. HR and confidence intervals were derived 
from a Cox regression model.*Confidence intervals. ᶿ P-value was derived from Wald test. BCS: Blantyre 
coma score. ᵜHistory of current disease reported by the child carer. ᵑHospital deaths and deaths in the 
first 24h omitted. 
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Table 2: Estimation of predictive models derived from the primary model including 
predictors associated to post-discharge death among 20506 observations of children 
less than 15 years old and 750 deaths in the first 90 days following discharge. 
  PRIMARY MODEL MODEL 2  MODEL 3 
Characteristics 
on admission 
Adjusted 
HRᵠ 
95 % CI* 
p 
valueᶿ 
Adjusted 
HRᵠ 
95 % CI* 
p 
valueᶿ 
Adjusted 
HRᵠ 
95 % CI* 
p 
valueᶿ 
Demographic 
characteristics                   
Age      <0·001     <0·001     0·002 
< 3 months  1·00     1·00     1·00     
4 to < 1year 0·92 0·71 to 1·20   0·93 0·72 to 1·20 0·041 0·79 0·62 to 1·03   
1 to 5 years 0·69 0·53 to 0·91   0·71 0·54 to 0·92 <0·001 0·66 0·51 to 0·86   
> 5 years 0·54 0·38 to 0·76   0·54 0·38 to 0·76 <0·001 0·55 0·39 to 0·77   
Rainy Season 1.22 1.03 to 1.43 0·018 1.22 1.04 to 1.44 0·017 1.25 1·07 to 1·46 0·005 
Anthropometric  
characteristics  
                  
Nutrition status 
by WHZᶤ z-score 
    <0·001     <0·001     <0·001 
>-1 SDᶧ 1·00     1·00     1·00     
>-2 to <-1 SDᶧ 1·23 0·75 to 2·01   1·27 0·77 to 2·07   1·32 0·81 to 2·14   
>-3 to <-2 SDᶧ 2·40 1·49 to 3·87   2·44 1·51 to 3·93   2·30 1·41 to 3·75   
< -3 SDᶧ 3·26 2·08 to 5·12   3·28 2·08 to 5·16   4·16 2·71 to 6·40   
Unknown 2·99 2·12 to 4·21   3·09 2·19 to 4·35   3·72 2·64 to 5·23   
History of 
current diseaseᵜ                   
History of 
diarrhoea 1·72 
1·45  to 2·03 <0·001 
1·70 
1·44 to 2·01 <0·001 
1·58 
1·32  to  1·89 <0·001 
History of cough 1·32 1·07 to 1·62 0·009 1·31 1·07 to 1·61 0·010 1·25 1·02 to 1·53 0·030 
History of 
breathing 
difficulties  
__ __ __ __ __ __ 
1·36 
1·09 to 1·70 0·007 
Symptoms and 
signs on 
admission                   
Increased 
respiratory rate 1·41 1·18  to  1·68 
<0·001 
1·42 1·19 to 1·69 
<0·001 
1·27 1·07  to  1·52 
0·007 
Skin pinch goes 
back slowly  
__ __ __ __ __ __ 
1·51 
1·20 to 1·90 <0·001 
Nasal flaring 0·69 0·55 to 0·86 <0·001 0·69 0·56 to 0·87 0·001 0·79 0·65 to 0·97 0·022 
Auscultatory 
crackles 1·37 1·12 to 1·67 
0·002 
1·41 1·16 to 1·71 
<0·001 
1·44 1·19 to 1·75 
<0·001 
Oral candidiasis 2·64 1·98  to 3·52 <0·001 2·72 2·03 to 3·64 <0·001 3·51 2·70  to 4·58 <0·001 
Oedema (any 
location) 1·86 
1·39  to  2·48 <0·001 
1·83 
1·67 to 2·44 <0·001 
2·48 
1·88 to  3·27 <0·001 
Depigmented or 
redish hair 2·03 
1·60 to 2·57 <0·001 
2·08 
1·64 to 2·64 <0·001 
2·42 
1·90 to 3·07 <0·001 
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Swollen lymph 
nodes 
1·89 1·42  to 2·51 <0·001 1·87 1·41 to 2·49 <0·001 2·23 1·70  to 2·93 <0·001 
Ear discharge 1·76 1·20 to  2·58 0·004 1·74 1·16 to  ·59 0·007 1·76 1·24 to  2·49 0·001 
Prostration 1·42 1·15  to  1·75 0·001 1·44 1·17 to 1·77 <0·001 1·41 1·15  to  1·73 0·001 
Investigations 
                  
Malaria 
diagnosis   
  <0·001 
  
  <0·001 
EXCLUDED 
Negative 1·00     1·00     
Positive 0·44 0·36 to 0·54   0·43 0·35 to 0·52   
Test not done 0·86 0·46 to 0·73   0·84 0·68 to 1·04   
Positive blood 
culture 
      
EXCLUDED Negative 1·00     
Positive 1·68 1·33 to 2·12 <0·001 
HIV status     <0·001     <0·001 
Test not done 1·00     1·00     
Negative 0·53 0·35to 0·80   0·53 0·35 to 0·80   
Positive 1·77 1·07 to 2·91   1·80 1·07 to 3·01   
Outcome of the 
admissionᵑ                   
      <0·001     <0·001       
Alive 1.00     1.00     EXCLUDED 
Absconded 5·23 4·22  to 6·50   5·50 4·45 to 6·79   
 
Transferred 4·48 3·31 to 6·05   4·57 3·36 to 6·21    
ᶧ WHZ: weight for height. ᶧSD: standard deviation. See definitions in Table S1. ᵝIt refers both community 
deaths and deaths in a readmission during follow-up period. ᵠHR: Hazard ratios. HR and confidence 
intervals were derived from a Cox regression model .*Confidence intervals.  ᶿ P-value was derived from 
Wald test.  ᵜHistory of current disease reported by the child carer. ᵑHospital deaths and deaths in the 
first 24h omitted. ᵟAUC: area under the curve. 
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Table 3: Model’s characteristics at probability cut-offs ensuring sensitivity of >80% 
 
 
ᶽAUC: area under the curve; *CI: confidence intervals. ᵑPPV: positive predictive value. 
 
 
 
 
 
 
 
Model AUCᶽ  (95% CI)* Score cut point Sensitivity (%) Specificity (%) PPVᵑ (%) 
  Day 30 Day 60 Day 90 Day 30 Day 60 Day 90 Day 30 Day 60 Day 90 Day 30 Day 60 Day 90 Day 30 Day 60 Day 90 
Primary model (training) 0.81 (0.76 - 0.86) 0.80 (0.76 - 0.84) 0.79 (0.75 - 0.82) 1.09 1.08 1.08 84.3 83.0 80.3 60.0 60.0 60.0 4.2 6.0 6.9 
Primary model (validation) 0.85 (0.83 - 0.87) 0.83 (0.81 - 0.85) 0.83 (0.81 - 0.84)                         
Model 2 0.81 (0.76 - 0.86) 0.80 (0.76 - 0.84) 0.78 (0.75 - 0.82) 1.10 1.09 0.93 83.5 82.6 83.0 60.0 60.1 55.0 4.2 6.0 6.4 
Model 3 0.78 (0.72 - 0.82) 0.75 (0.71 - 0.79) 0. 75 (0.71 - 0.78) 1.53 1.53 1.53 84.6 82.9 80.6 54.6 54.9 55.0 3.8 5.3 6.2 
Model 4 0.84 (0.72 - 0.91) 0.76 (0.64 - 0.85) 0.76 (0.72 - 0.91) 0.9 0.5 0.5 87.0 78.8 78.7 64.1 52.6 52.9 11.4 11.6 12.8 
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Figure S1. Flow chart on how hospital readmissions of children were selected. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
Both admissions included in 
the analysis as independent 
records.  
 
 
 
 
Admission 
1
Admission 
2Discharge* Discharge
* 
Scenario 1 
> 90 
 
 
 
 
Admission 
1
Admission 
2
Discharge* Discharge
* 
Scenario 2 
≤ 90 
Admission 2 excluded from the 
analysis given is a readmission 
within the follow-up period. In 
this case, admission 1 is taken 
as reference.   
 
 
 
Admission 
1
Admission 
2
Discharge* Hospital death 
Scenario 2 
≤ 90  
Admission 2 excluded from the 
analysis giving it is a readmission 
within the follow-up period. In 
this case, admission 1 is taken as 
reference but the outcome of 
admission is hospital death 
within follow-up   
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Figure S2: Number of admissions and post-discharge deaths in the first 90 days of 
follow-up by year. 
 
 
Figure S3: Time-varying area under the curve of predictive models estimated from 
primary model. 
   
 
 
A) Comparison among primary model and estimated models 2 and 3. B) Comparison 
between training and validation set of estimated model 4 which includes exclusively 
infants <3 months. 
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Figure S4: Number of admissions due to specific diseases over time 
  
                                          
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
0
2
4
6
8
1
0
R
a
te
 (
p
e
r 
1
0
0
0
)
20
00
20
01
20
02
20
03
20
04
20
05
20
06
20
07
20
08
20
09
20
10
20
11
20
12
20
13
20
14
20
15
20
16
Year
Number of admissions due to malaria
5
6
7
8
9
1
0
R
a
te
 (
p
e
r 
1
0
0
0
)
20
00
20
01
20
02
20
03
20
04
20
05
20
06
20
07
20
08
20
09
20
10
20
11
20
12
20
13
20
14
20
15
20
16
Year
Number of admissions due to severe acute malnutrition
Number of admissions due to HIV
0
2
4
6
R
a
te
 (
p
e
r 
1
0
0
0
)
20
00
20
01
20
02
20
03
20
04
20
05
20
06
20
07
20
08
20
09
20
10
20
11
20
12
20
13
20
14
20
15
20
16
year
Page 34 of 46
https://mc.manuscriptcentral.com/pediatrics
Confidential - Not for Circulation
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
Review Copy
5 
 
Table S1: Definitions 
Rainy Season November to April 
Blantyre coma scale (BCS):  Based on pain response, cry or verbal response, eyes movement. Score 0 to 5 
  ·        Normal: 5  
  ·        Impaired consciousness: 3-4 
  ·        Coma: ≤ 2  
WHZ Weight-for-height z-score calculated using the WHO growth chart 
  ·       >-1 DS: well nourished 
  ·       >-2 to <-1DS: mild acute malnutrition 
  ·       >-3 to <-2DS: moderate acute malnutrition 
  ·       <-3DS: severe acute malnutrition 
WAZ   Weight-for-age z-score calculated using the WHO growth chart 
  ·       <-3DS: underweight 
Malaria A malaria case was defined as a child admitted with a clinical diagnosis of 
malaria with a positive P. falciparum asexual parasitaemia. 
Increased Respiratory Rate (IRR) 
  
• IRR in < 2 months old children  = respiratory rate ≥ 60 
• IRR in 2 - <12 months old children  = respiratory rate ≥ 50 
• IRR in 12 - <60 months old children  = respiratory rate ≥ 40 
• IRR in 60 - <120 months old children  = respiratory rate ≥ 30 
• IRR ≥ 120 months old children  = respiratory rate ≥ 20 
Heart rate normal ranges in 
beats per minute: 
  
  ·        0 to 1 year: 110-160 
  ·        1 -2 years: 100-150 
  ·        2-5 years:95-140 
  ·        5-12 years: 80-120 
  ·        >12 years: 60-100 
    
Non-severe anaemia · Children ≤ 28 days old with a packed cell volume (PCV) between 25- <42%                                                                                                    
  · Children >28 days: PCV between 15- <33% 
Severe anaemia · Children ≤ 28 days old= PCV <25%  
  
· Children >28 days: PCV <15% 
Hypoglycaemia Blood glucose levels <3.0 mmol/L (categorized as severe if <2.5 mmol/L) 
Hyperglycaemia Blood glucose levels >11.0 mmol/L (categorized as severe if <2.5 mmol/L) 
Hypothermia Axillary temperature < 35°C 
Verbal autopsy 
 
Research method based on a structured interview conducted to family 
members of the deceased individual that helps to determine the probable 
causes of death in cases where there was no medical record or formal 
medical attention given, validated by World Health Organization  
 
 
 
 
Page 35 of 46
https://mc.manuscriptcentral.com/pediatrics
Confidential - Not for Circulation
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
Review Copy
6 
 
Table S2: Socio-demographic, clinical characteristics and univariate analysis of 
predictors on admission associated to post-discharge mortality among 2055 
observations of infants less than 3 months of age and 126 post-discharge deaths in 
southern Mozambique. 
Characteristics on admission 
Total 
observations 
included         
N= 2055,             
n (%)       
Infants < 
3months dying 
within 90 day 
after dischargeᵝ     
N= 126,   n (%ʱ) 
Univariateᶽ 
HRᵠ 
95 % CI* p valueᶿ 
Demographic characteristics           
Age               
< 28 days  945 (46·0) 80 (8·5) 1·00     
≥ 28 days to < 3months 1110 (54·0) 46 (5·3) 0·48 0·33  to  0·69 <0·001 
Female sex  934 (45·6) 61 (6·5) 1·12 0·79 to 1·60 0·502 
Rainy season 1239 (60·3) 74 (6·0) 0·94 0·66 to 1·33 0·711 
Anthropometric  
characteristics  
          
Weight for age-z score(mean 
±SDᶧ) 
 
 -0·22 (0·03) 
 
 
 -1·55 (0·12) 
 
0·52 
 
0·46 to 0·58 
 
<0·001 
Nutrition status by WAZᶤ z-
score 
        <0·001 
>-1 SDᶧ 1458 (71·0) 38 (2·6) 1·00     
>-2 to <-1 SDᶧ 312 (15·2) 35 (11·2) 4·50 2·85 to 7·12 <0·001 
>-3 to <-2 SDᶧ 155 (7·5) 29 (18·7) 7·90 4·87 to 12·83 <0·001 
< -3 SDᶧ 61 (3·0) 17 (27·9) 12·14 6·90 to 21·35 <0·001 
Unknown 69 (3·4) 7 (10·1) 4·05 1·81 to 9·07 <0·001 
History of current diseaseᵜ           
Current breastfeeding 1489 (72·5) 91 (6·1) 0·43 0·25 to 0·75 0·003 
History of fever 1660 (80·8) 101 (6·1) 0·96 0·62 to 1·49 0·853 
History of cough 1326 (64·5) 95 (7·2) 1·71 1·14 to 2·56 0·010 
History of diarrhoea 1706 (83·0) 28 (1·6) 1·44 0·94 to 2·19 0·094 
History of vomiting 1713 (83·4) 35 (2·0) 1·98 1·34  to 2·93 0·001 
History of breathing 
difficulties 
748 (20·8) 64 (8·6) 
1·81 
1·28 to 2·58 0·001 
Anorexia 168 (8·2) 19 (11·3) 2·07 1·27 to 3·39 0·004 
History of  seizures  42 (2·0) 3 (7·1) 1·16 0·37 to 3·61 0·795 
Symptoms and signs on 
admission 
          
Axillary temperature  (ºC)          0·0361 
Normothermia (35.5-37.4ºC) 1081 (52·7) 54 (5·0) 1·00     
Hypothermia (<35.5ºC) 51 (2·5) 6 (11·8) 2·46 1·05 to 5·73 0·037 
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Fever (≥37.5ºC) 919 (44·8) 65 (7·1) 1·43 1·00 to 2·06 0·051 
Heart rate         0·647 
Normal 1352 (65·8) 86 (6·4) 1·00     
Bradycardia 169 (8·2) 9 (5·3) 0·84 0·42 to 1·67 0·616 
Tachycardia 534 (25·9) 31 (5·8) 0·91 0·60 to 1·36 0·634 
Increased respiratory rate 1101 (53·8) 86 (7·8) 1·93 1·32 to 2·82 0·001 
Skin pinch goes back slowly  113 (5·5) 13 (11.5) 2·03 1·14 to 3·60 0·015 
Dehydration 244 (11·9) 25 (10·2) 1·90 1·22 to 2·95 0·004 
Pallor 126 (6·1) 6 (4·8) 0·76 0·33 to 1·72 0·510 
Jaundice 42 (2·0) 3 (7·1) 1·14 0·37 to 3·49 0·813 
Oedema (any location) 28 (1·4) 2 (7·1) 1·14 0·29 to 4·48 0·845 
Skin flaking off 61 (3·0) 4 (6·6) 1·06 0·40 to 2·84 0·906 
Depigmented or redish hair 17 (0·8) 3 (17·6) 3·19 0·99 to 10·27 0·052 
Oral candidiasis 79 (3·9) 22 (27·8) 6·18 3·87 to 9·85 <0·001 
Swollen lymph nodes 23 (1·1) 6 (26·1) 4·73 2·16 to 10·36 <0·001 
Conjunctivitis 69 (3·4) 6 (8·7) 1·46 0·64 to  3·31 0·366 
Ear discharge 46 (2·2) 4 (8·7) 1·46 0·54 to  3·98 0·457 
Lower chest wall indrawing 795 (38·8) 61 (7·7) 1·50 1·06  to 2·13 0·022 
Nasal flaring 582 (28·3) 38 (6·5) 1·10 0·75  to 1·60 0·631 
Pathological breathing 
pattern 
138 (6·7) 11 (8·0) 1·34 0·72 to 2·49 0·350 
Auscultatory crackles 572 (27·9) 49 (8·6) 1·68 1·17 to 2·40 0·005 
Wheeze/roncus 361 (17·6) 22 (6·1) 0·99 0·63 to 1·57 0·977 
Heart gallop 37 (1·8) 2 (5·4) 0·86 0·22 to 3·38 0·828 
Palpable liver 35 (1·7) 3 (8·6) 1·41 0·45 to 4·35 0·554 
Palpable spleen 158 (21·0) 9 (7·1) 0·92 0·47 to 1·80 0·799 
Abnormal fontanel  112 (5·6) 7 (6·3) 1·02 0·47 to 2·21 0·958 
Prostration 398 (20·5) 25 (6·3) 1·06 0·68 to 1·66 0·782 
BCS on admission          0.923 
Normal (BCS=5) 1851 (90·3) 115 (6·2) 1·00     
Abnormal BSC (BCS=3-4) 164 (8·0) 9 (5·5) 0·88 0·44 to 1·72 0·701 
Deep coma (BCS≤2) 35 (1·7) 2 (5·7) 0·91 0·23 to 3·67 0·898 
Investigations           
Malaria diagnosis         <0·072 
Negative 1257 (61·2) 88 (7·0) 1·00     
Positive 414 (20·2) 16 (3·9) 0·54 0·32 to 0·93 0.025 
Test not done 384 (18·7) 22 (5·7) 0·81 0·51 to 1·29 0·389 
Glycaemia         0.988 
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Normoglycaemia                   
(2.5-11.0 mmol/l) 
1799 (87·5) 110 (6·1) 1·00     
Hypoglycaemia (<2.5 mmol/l) 163 (7·9) 10 (6·1) 1·00 0·53 to 1·93 0·984 
Hyperglycaemia                 
(>11.0 mmol/l) 93 (4·5) 6 (6·5) 1·07 0·47 to 2·45 0·877 
Blood culture           
Negative 1881 (91·7) 110 (5·8) 1·00     
Positive 171 (8·3) 16 (9·4) 1·62 0·96 to 2·72 0.071 
Anaemia         0·008 
No anaemia 951 (46·3) 41 (4·3) 1·00     
Mild to moderate anaemia 845 (41·1) 64 (7·6) 1·78 1·20 to 2·63 0·004 
Severe anaemia 259 (12·6) 21 (8·1) 1·90 1·12 to 3·21 0·017 
HIV status         0·001 
Test not done 1850 (90·0) 115 (6·2) 1·00     
Negative 185 (9·0) 6 (3·2) 0·52 0·23 to 1·18 0·115 
Positive 20 (1·0) 6 (25·0) 4·50 1·94 to 11·04 0·001 
Outcome of the admissionᵑ           
          <0·001 
Discharged alive 1906 (92·8) 91 (4·8) 1·00     
Absconded 85 (4·1) 19 (22·4) 5·23 3·19 to 8·59 <0·001 
Transferred 64 (3·1) 16 (25·0) 6·31 3·61 to 11·02 <0·001 
ᶧSD: standard deviation. ᶤWAZ: Weigh-for-age. ᵝIt refers both community deaths and deaths in a 
readmission during follow-up period. ʱPercentage represents risk among children with same 
characteristics. ᶽUnivariate model based on 2055 infants under 3 months and 126 deaths. ᵠHR: Hazard 
ratios. Hazard ratios and confidence intervals were derived from a Cox regression model.*Confidence 
intervals.  ᶿ P-value was derived from Wald test. ʶValidated predictive model base of 80% of data (1636 
infants). BCS: Blantyre coma score. ᵜHistory of current disease reported by the child carer. ᵑHospital 
deaths omitted. 
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Table S3: Socio-demographic and clinical characteristics of children <15 years 
admitted at MDH comparing training (80% of data) and validation set (20% of data). 
Characteristics at admission 
Training set,                      
N= 20506, n (%)       
Validation set,         
N= 5126,   n (%ʱ) 
p value ᶿ 
Demographic characteristics       
Age         0·935 
< 3 months  1655 (8·0) 400 (8·0)   
4 to < 1year 4162 (20·0) 1041 (20·0)   
1 to 5 years 11635 (57·0) 2923 (57·0)   
> 5 years 3054 (15·0) 762 (15·0)   
Sex       
Male 11234 (55·0) 2746 (54·0)   
Femal  9206 (45·0) 2365 (46·0) 0·113 
Rainy season 12464 (61·0) 3160 (62·0) 0·257 
Anthropometric  
characteristics  
      
Nutrition status by WHZᶤ z-
score 
  0·540 
>-1 SDᶧ 4822 (24·0) 1172 (23·0)   
>-2 to <-1 SDᶧ 2210 (11·0) 539 (11·0)   
>-3 to <-2 SDᶧ 1178 (6·0) 308 (6·0)   
< -3 SDᶧ 808 (4·0) 222 (4·0)   
Unknown 11488 (56·0) 2885 (56·0)   
Nutrition status by WAZᶽ z-
score 
  0·538 
>-1 SDᶧ 8326 (41·0) 2078 (41·0)   
>-2 to <-1 SDᶧ 5379 (26·0) 1376 (27·0)   
>-3 to <-2 SDᶧ 3375 (16·0) 815 (16·0)   
< -3 SDᶧ 2314 (11·0) 599 (12·0)   
Unknown 1112 (5·0) 258 (5·0)   
History of current diseaseᵜ       
Current breastfeeding 5976 (29·0) 1545 (30·0) 0·224 
History of fever 18766 (92·0) 4658 (91·0) 0·147 
History of cough 13061 (64·0) 3262 (64·0) 0·957 
History of diarrhoea 4032 (20·0) 983 (19·0) 0·431 
History of vomit 4827 (24·0) 1177 (23·0) 0·372 
History of difficulty breathing 4258 (21·0) 1045 (20·0) 0·503 
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Anorexia 1317 (6·0) 331 (6·0) 0·926 
Blood in urine 77 (0·0) 20 (0·0) 0·878 
History of  seizures  2105 (10·0) 553 (11·0) 0·278 
Symptoms and signs on 
admission 
      
Axillary temperature  (ºC)      0·366 
Normothermia (35.5-37.4ºC) 7532 (37·0) 1948 (38·0)   
Hypothermia (<35.5ºC) 395 (2·0) 118 (2·0)   
Hyperthermia (≥37.5ºC) 12548 (61·0) 3050 (60·0)   
Heart rate (mean±SD)     0·414 
Normal 13331 (65·0) 3366 (66·0)   
Bradycardia 1543 (8·0) 359 (7·0)   
Tachycardia 1375 (27·0) 5501 (27·0)   
Increased respiratory rate 9256 (45·0) 2304 (45·0) 0·791 
Skin pinch goes back slowly  1591 (8·0) 416 (8·0) 0·397 
Dehydration 3128 (15·0) 779 (15·0) 0·921 
Pallor 3376 (16·0) 852 (17·0) 0·792 
Jaundice 253 (1·0) 75 (1·0) 0·191 
Oedema (any location) 1082 (5·0) 289 (6·0) 0·304 
Skin flaking off 358 (2·0) 106 (2·0) 0·121 
Depigmented or redish hair 1158 (6·0) 302 (6·0) 0·499 
Oral candidiasis 379 (2·0) 114 (2·0) 0·080 
Swollen lymph nodes 665 (3·0) 162 (3·0) 0·766 
Conjuntivitis 333 (2·0) 83 (2·0) 0·981 
Ear discharge 518 (3·0) 123 (2·0) 0·603 
Lower chest wall indrawing 4406 (22·0) 1082 (21·0) 0·557 
Nasal flaring 3297 (16·0) 826 (16·0) 0·957 
Pathological breathing 
pattern 
793 (4·0) 225 (4·0) 0·087 
Auscultatory crackles 4253 (21·0) 1061 (21·0) 0·951 
Wheeze/roncus 2480 (12·0) 610 (12·0) 0·709 
Heart gallop 720 (4·0) 162 (3·0) 0·218 
Palpable liver 523 (3·0) 154 (3·0) 0·007 
Palpable spleen 4296 (21·0) 1082 (21·0) 0·804 
Neck stiffness 167 (1·0) 36 (1·0) 0·417 
Abnormal fontanella (among 
applicable) 
760 (4·0) 162 (3·0) 0·158 
Prostration 2606 (13·0) 655 (13·0) 0·987 
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BCS at admission      0·221 
Normal (BCS=5) 19476 (95·0) 4844 (95·0)   
Abnormal BSC (BCS=3-4) 683 (3·0) 190 (4·0)   
Deep coma  (BCS≤2) 308 (2·0) 88 (2·0)   
Investigations       
Malaria diagnosis     0·750 
Negative 7529 (37·0) 1902 (37·0)   
Positive 9810 (48·0) 2422 (47·0)   
Test not done 3167 (15·0) 802 (16·0)   
Glycaemia     0.478 
Normoglycaemia (2.5-11.0 
mmol/l) 
17124 (84·0) 4260 (83·0)   
Hypoglycaemia (<2.5 mmol/l) 1934 (9·0) 479 (9·0)   
Hyperglycaemia (>11.0 
mmol/l) 1448 (7·0) 387 (8·0)   
Blood culture     0·473 
Negative 19436 (95·0) 4880 (95·0)   
Positive 1054 (5·0) 242 (5·0)   
Test not done 16 (0·0) 4 (0·0)   
Anemia     0·420 
Non anemia 7019 (34·0) 1787 (35·0)   
Non-severe anaemia 10900 (53·0) 2724 (53·0)   
Severe anaemia 2587 (13·0) 615 (12·0)   
HIV status     0·638 
Test not done 19298 (94·0) 4830 (94·0)   
Negative 1006 (5·0) 240 (5·0)   
Positive 202 (1·0) 56 (1·0)   
Outcome of the admissionᵑ       
      0·217 
Alive 19340 (94·0) 4805 (94·0)   
Absconded 637 (3·0) 168 (3·0)   
Transferred 529 (3·0) 153 (3·0)   
        
ᶧSD: standard deviation. ᶤWHZ: Weigh-for-height.See definitions in Table S1.ᶽWAZ: Weight-for-age. ᵝIt 
refers both communitary deaths and deaths in a readmission during follow-up period. ʱPercentage 
represents risk among children with same chacarteristics. ᵠHazard ratios and confidence intervals 
were derived from a Cox regression model.*Confidence intervals. ᶿ P-value was derived from Wald 
test. BCS: Blantyre coma score. ᵜHistory of current disease reported by the child carer. ᵑHospital 
deaths ommited. 
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Table S4: Estimation of a predictive model including predictors associated to post-
discharge death among 1655 observations of infants less than 3 months old and 94 
deaths in the first 90 days following discharge.   
Characteristics on 
admission 
Adjusted HRᵠ 95 % CI* p valueᶿ 
Demographic 
characteristics 
      
Age           
< 28 days  1·00     
≥ 28 days to < 3months 0·43 0·33  to  0·68 <0·001 
Anthropometric  
characteristics  
      
Nutrition status by WAZᶤ z-
score 
    <0·001 
>-1 SDᶧ 1·00     
>-2 to <-1 SDᶧ 4·53 2·51 to 8·19   
>-3 to <-2 SDᶧ 7·03 3·87 to 12·77   
< -3 SDᶧ 13·49 7·43 to 24·51   
Unknown 5·11 1·77 to 14·72   
History of current diseaseᵜ       
History of breathing 
difficulties  1·68 
1·13 to 2·52 0·011 
Symptoms and signs on 
admission 
      
Axillary temperature (ºC)      0·020 
Normothermia (35.5-
37.4ºC) 
1·00     
Hypothermia (<35.5ºC) 2·30 1·04 to 5·11   
Fever (≥37.5ºC) 1·67 1·10 to 2·53   
Oral candidiasis 4·32 2·51 to 7·43 <0·001 
Outcome of the admissionᵑ       
      <0·001 
Discharged alive 1·00     
Absconded 5·23 2·97 to 9·20   
Transferred 5·92 2·78 to 12·64   
ᶧSD: standard deviation. ᶤWAZ: Weigh-for-age. ᵝIt refers both community deaths and deaths in a 
readmission during follow-up period. ᵠHR: Hazard ratios. HR and confidence intervals were derived from 
a Cox regression model.*Confidence intervals.  ᶿ P-value was derived from Wald test. BCS: Blantyre 
coma score. ᵜHistory of current disease reported by the child carer. ᵑHospital deaths omitted. 
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and legend for this graphic 
 
The title & legend of this graphic was entered through the submission website 
and updated in the corresponding figure. It is “The time-varying area under the 
curve of primary model comparing training and validation sets.”  
Legend: “___ Training set (80% data) 
----- Validation set (20% data)”.   
Figure 4  
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Table 1:  
o    I assume that not all variables were 
documented for all patients; these would 
be a comprehensive list of variables to 
collect uniformly even with prospective 
data collection. Were variables assumed 
to be negative unless documented as 
positive? Given the challenges to 
documentation, this is probably not an 
accurate assumption. Would it be possible 
to provide the denominator for the # of 
children in whom a given symptom was 
documented (as positive or negative)?  
 
We did not include missing values for all variables as given the number of 
variables studied, the table would be endless. We followed the following 
methodology: For those variables with high proportion of missing values (>15%), 
we generated a new category for each variable called unknown or test not done 
to assess the effect of missing values and allow inclusion of more observations in 
the final model.  
This was already explained in methods “Data management & analysis”, but we 
have added a further explanation: “For each variable with a high proportion of 
missing values (<15%) but suspected to be a strong confounder, a “missing or 
unknown” category was created”  
Page 8, lines 12-
13 
 
The model created has a very high AUC. 
However, the model would also apply to a 
large percentage of children admitted to 
inpatient units. As such, how would you 
apply the findings prospectively to reduce 
post-discharge mortality? I think a 
particular challenge would be how to avoid 
PDM beyond 30 days, as this may be due 
to a different illness and may be less 
amenable to intervention strategies than 
the < 30d PDM.  
More than half of deaths occurred in the first 30 days. Then strategies would 
focus in avoiding death in this period. As explained in figure 1 and discussion, 
and seen in AUC (figure 3 in supplementary information) the model is better to 
predict deaths in these first 30 days. We have added some comments on top of 
what was stated in the previous version:  “Once identified, these children at 
higher risk of PDM could benefit from strategies to prevent post-discharge death 
and these strategies should especially focus in the first 30 days after discharge as 
it is the period with the highest risk of PDM. Community-based interventions 
driven by community-health workers consisting in pre and post-natal home visits, 
supporting low birth-weight (LBW) infants and sepsis case management, 
facilitating referral in case of need have reduced neonatal and infant mortality in 
several countries
31
. Although these interventions have not been explored in 
children after a hospital admission, their impact reducing PDM could be similar. 
Alternative strategies, utilizing the prophylactic use of antimicrobials in those 
children at high risk should also be explored.“ 
Page 15, lines 
18-25 
 
Why do you think there is higher mortality 
during the rainy season if it is not (page 
11, line 50) associated with malaria?  
 
This is because >60% of total admissions were in the rainy season and not only 
because of malaria but also due other causes including severe malnutrition 
(>60%) or HIV associated admissions (54%). Additionally, more children 
absconded (>60%) or were transferred to referral hospital (<60%) during the 
rainy season, and both are stronger predictors of PDM. We have added a 
comment in discussion: “Rainy season was also associated to higher risk of PDM 
as more children are admitted during this season, likely due to the greater 
number of admissions and severe disease occurring in this season” 
Page 14, lines 
12-15 
 
•    Why do you think children with 
unknown WHZ scores had the same 
hazard ratio for mortality as children with 
severe malnutrition?   
We explained this fact in draft versions, but due to limitation of words, we 
decided to remove it. We have added to discussion the following comment: “On 
the other hand, children with unknown nutritional status had higher risk of dying 
compared to well-nourished children. This may be partly explained in cases of 
Page 14, lines 7-
11. 
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severe disease, where the severity of the child upon admission did not allow 
collecting anthropometrics measurements.” 
Reviewer  2´s comments:    
Given the lower specificity and PPV, the 
authors may need to recognize that many 
children will screen "positive" with their 
model. This does not mean it's still not a 
valuable output. It could, however, make 
interventions difficult. I think this warrants 
at least a line in the discussion. Given 
their AUC, spec / sens / PPV, I wouldn't 
be surprised if 50% of admitted children 
screened "positive". Doing an intervention 
in this case, would mean it needs to be 
really feasible. Might the model perhaps 
be most useful at identifying the kids who 
are unlikely to die rather than those most 
likely to die? 
 
We agree with this comment and have added the following sentence in the 
discussion: “On the other hand, the low specificity and positive predictive 
value found could compromise feasibility of interventions to prevent PDM, 
as a high number of children would be classed as high risk of dying after 
discharge. However, these models would allow the identification of the 
majority of children with risk of PDM.”   
Page 17, lines 3-
8 
 
If the authors can reduce acronyms (e.g., 
U5 for "under five" is probably not 
necessary), it would help readability. I 
recommend trying to limit to only 
established abbreviations and minimizing 
use in the abstract.  
We have removed some acronyms such as U5 through the manuscript.  We have 
used four acronyms in the abstract, three of them internationally accepted (HIV, 
WAZ & AUC). The only acronym introduced by authors is postdischarge mortality 
(PDM).  
Across the 
manuscript 
 
The supplement definitions are important 
but pretty dense. This is in part because 
there are so many. An ideal world 
situation would be that the predictors are 
streamlined enough that these definitions 
could be included in the methods. Do they 
still feel each should remain?  
 
Following the reviewer’s suggestion, we have reduced the number of definitions, 
removing those clinical definitions which are internationally known.  
Supplementary 
information, 
table S1 
 
Related to this - did the authors consider 
using any statistical corrections for 
multiple testing?  
Correction for multiple comparisons was not performed because of the 
exploratory character of the research to make sure that all important 
associations were identified. Therefore, both the hypotheses emanating from 
previous studies and the robustness of the findings of this study were two key 
issues for the discussion of the results. 
NA  
There are a lot of tables / figures - I think I 
count 9, many of which have multiple sub-
figures. The tables also span multiple 
pages. I assume this will all have to be 
trimmed significantly. As a start, Table 2 / 
4 might not be necessary in the primary 
analysis - consider moving to appendix or 
Following reviewer’s recommendations we have moved table 2 and 4 to the 
supplementary information section.  
Supplementary 
information, 
table S2 and 
S4 
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a subsequent paper. 
Can the authors please define what are 
verbal autopsies. 
 
We have included this definition in Supplementary information, supplementary 
Table S1. 
Supplementary 
information, 
table S1 
 
Can the authors please add what was the 
high proportion threshold above which a 
“missing” category was created? 
As explained in a comment from reviewer #1, authors have added a further 
explanation: “For each variable with a high proportion of missing values (<15%) 
but suspected to be a strong confounder, a “missing or unknown” category was 
created” 
Page 8, lines 12-
13 
 
 
 
Instructions: 
Please use this table format to answer the questions posed by the editors and reviewers of your paper. Copy and paste the editor/reviewer’s question in the  
“Comments” column and your answer to that question in the corresponding “Response” column. Be sure to ALSO paste the corrected text along with your response. 
For minor copyediting changes such as spelling and grammar corrections, you may simply state that the error was corrected, without pasting the altered text. 
* Use the page/line numbers from your revised .doc, .rtf, or .txt file; do not use the page/line numbers from the submission system’s auto-generated PDF.  
 
For clarity, use one row per question. Make sure to list th  page and line reference where your change can be found. If no change was made, please make sure to note 
that in your response in addition to your reasoning. You may delete the sample row and insert rows to this table as needed.   
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